OpenAlex
PricingAboutJobs
Log inGet started
Work

How I manage ibrutinib-refractory chronic lymphocytic leukemia

HTML

Year: 2017
Type: article
Source: Blood
DOI: 10.1182/blood-2016-09-693598
Author: Jennifer A. Woyach
Institution: The Ohio State University
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: BTK inhibitors, ibrutinib, BTK mutations, PLCG2 mutations, relapse diagnosis, long-term disease control
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Awards: Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies, Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia, Improving BTK Directed Therapy for CLL
OpenAlex ID: W2575189453
FWCI: 6.506
Cites: 28
Cited by: 55
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security